Company Quick10K Filing
Zomedica Pharmaceuticals
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-Q 2019-09-30 Quarter: 2019-09-30
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
8-K 2019-12-02 Officers, Regulation FD, Exhibits
8-K 2019-11-12 Earnings, Exhibits
8-K 2019-11-05 Shareholder Vote
8-K 2019-09-16 Officers, Regulation FD, Exhibits
8-K 2019-08-16 Officers, Regulation FD, Exhibits
8-K 2019-08-08 Earnings, Exhibits
8-K 2019-05-20 Other Events
8-K 2019-05-10 Earnings, Exhibits
8-K 2019-03-26 Enter Agreement, Other Events, Exhibits
8-K 2019-02-26 Earnings, Exhibits
8-K 2018-12-20 Other Events, Exhibits
8-K 2018-11-27 Enter Agreement, Other Events, Exhibits
8-K 2018-11-13 Earnings, Exhibits
8-K 2018-08-15 Shareholder Vote
8-K 2018-08-09 Earnings, Exhibits
8-K 2018-06-28 Other Events, Exhibits
8-K 2018-06-19 Other Events, Exhibits
8-K 2018-06-12 Officers
8-K 2018-05-10 Enter Agreement, Other Events, Exhibits

Zomedica Pharmaceuticals Financials

-

ZOM Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Advaxis (ADXS) 5,775 56,133 6,864 22,012 0 1,812 3,429 -35,980
Tonix Pharmaceuticals Holding (TNXP) 8,683 15,008 2,186 0 0 -23,639 -23,595 -3,567
Delmar Pharmaceuticals (DMPI) 3,296 4,037 2,070 0 0 8,048 8,048 -423
Diffusion Pharmaceuticals (DFFN) 1,924 18,929 2,752 0 0 -17,534 -17,962 -6,448
Phibro Animal Health (PAHC) 1,272 726,671 510,656 624,112 264,624 54,713 109,193 174,989
OHR Pharmaceutical (OHRP) 10,129 8,693 752 0 0 -9,529 -8,750 8,704
Therapix Biosciences (TRPX) 0 4,560 0 0 0 0 -1,518
Grifols (GRFS) 12,477,046 7,780,442 0 0 0 0 -592,178
Novo Nordisk (NVO)
Bioblast Pharma (ORPN) 39,270 11,034 1,328 0 0 -3,073 -3,073 29,534
Trillium Therapeutics (TRIL) 55,459 13,858 0 0 0 0 -0
Kiniksa Pharmaceuticals (KNSA) 308,137 32,940 0 0 -169,998 -170,154 -287,447
AstraZeneca (AZN) 60,651,000 46,607,000 0 0 0 0 -893,000
Immtech Pharmaceuticals (IMMP)
Zomedica Pharmaceuticals (ZOM) 9,479 1,797 0 0 -24,413 -24,124 -5,822
VTV Therapeutics (VTVT) 9,072 21,914 10,646 0 -6,924 -4,119 5,935
Nabriva Therapeutics (NBRV) 678,758 83,645 40,240 3,486 0 -125,573 -123,455 629,164
Affimed (AFMD) 116,174 0 0 0 0 -0
Zealand Pharma (ZEAL)
Intec Pharma (NTEC) 46,860 11,751 0 0 -20,665 -20,593 -20,796

Balance Sheet ($'000)2017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash3,4483,1354,2795271,9402,2975,822
Accounts Receivable28695038547896
Inventory
PP&E5105236489749871,1921,195
Assets5,2164,8966,4184,1916,0345,8949,479
Accounts Payable
Long-Term Debt
Liabilities8291,2661,6841,2802,3777,7741,797
Stockholders' Equity4,3873,6294,7342,9103,657-1,8807,683
Income Statement ($'000)2017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue
Cost of Revenue
Gross Profit
R&D6002,5356306,5527,5311,062
SG&A
Tax000000
Net Income-2,171-4,144-1,910-8,422-11,677-2,404
Cash Flow ($'000)2017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating-1,708-2,740-3,371-3,328-2,581-8,436
Cash Investing-13-124-468-14-69-5
Cash Financing1,4084,009864,7553,00711,967